Disease Info Card

Pseudoxanthoma Elasticum

Information about Pseudoxanthoma Elasticum: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Pseudoxanthoma Elasticum

Most recent studies have shown that Pseudoxanthoma Elasticum shares some biological mechanisms with angioid-streaks, calcinosis, cardiovascular-diseases, choroidal-neovascularization, connective-tissue-diseases, cutis-laxa, dermatologic-disorders, disorder-of-eye, ehlers-danlos-syndrome, elastoid-degeneration, elastosis-perforans-serpiginosa, eye-manifestations, gastrointestinal-hemorrhage, hemorrhage, hereditary-diseases, hypertensive-disease, marfan-syndrome, pathologic-neovascularization, retinal-diseases, vascular-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Pseudoxanthoma Elasticum, and have been seen in publications frequently: Aging, Cell Adhesion, Cellular Localization, Coagulation, Dna Methylation, Drug Resistance, Excretion, Fertilization, Gene Conversion, Hemostasis, Hypersensitivity, Localization, Methylation, Ossification, Pathogenesis, Pigmentation, Protein Carboxylation, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Pseudoxanthoma Elasticum, such as ABCB6, ABCC1, ABCC2, ABCC6, AHSG, CFTR, ELN, GGCX, GLA, MARCKSL1, MDM4, MGP, MSH3, NAT8, NT5E, RPE, S100A12, VEGFA, VTN, WLS. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.